130 related articles for article (PubMed ID: 28408249)
1. Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines.
Suzuki Y; Fujioka K; Ikeda K; Murayama Y; Manome Y
J Clin Neurosci; 2017 Jul; 41():144-149. PubMed ID: 28408249
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG).
Pazhouhi M; Sariri R; Khazaei MR; Moradi MT; Khazaei M
J Cancer Res Ther; 2018; 14(5):1023-1028. PubMed ID: 30197342
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
Zhang N; Wu X; Yang L; Xiao F; Zhang H; Zhou A; Huang Z; Huang S
Clin Cancer Res; 2012 Nov; 18(21):5961-71. PubMed ID: 22977194
[TBL] [Abstract][Full Text] [Related]
4. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
5. Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.
Wu L; Yang L; Xiong Y; Guo H; Shen X; Cheng Z; Zhang Y; Gao Z; Zhu X
Tumour Biol; 2014 Dec; 35(12):12327-37. PubMed ID: 25245332
[TBL] [Abstract][Full Text] [Related]
6. Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.
Zhang Z; Wang Y; Chen J; Tan Q; Xie C; Li C; Zhan W; Wang M
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1289-1296. PubMed ID: 27832326
[TBL] [Abstract][Full Text] [Related]
7. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
9. MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.
Chen Y; Li R; Pan M; Shi Z; Yan W; Liu N; You Y; Zhang J; Wang X
J Neurooncol; 2017 Jul; 133(3):477-485. PubMed ID: 28501897
[TBL] [Abstract][Full Text] [Related]
10. Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma.
Rajesh Y; Biswas A; Kumar U; Das S; Banerjee I; Banik P; Bharti R; Nayak S; Ghosh SK; Mandal M
Biochem Pharmacol; 2019 Jun; 164():1-16. PubMed ID: 30885764
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells.
Wen X; Huang A; Liu Z; Liu Y; Hu J; Liu J; Shuai X
PLoS One; 2014; 9(3):e92050. PubMed ID: 24642531
[TBL] [Abstract][Full Text] [Related]
12. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.
Trog D; Yeghiazaryan K; Fountoulakis M; Friedlein A; Moenkemann H; Haertel N; Schueller H; Breipohl W; Schild H; Leppert D; Golubnitschaja O
Eur J Pharmacol; 2006 Aug; 542(1-3):8-15. PubMed ID: 16806166
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
14. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.
Dong F; Eibach M; Bartsch JW; Dolga AM; Schlomann U; Conrad C; Schieber S; Schilling O; Biniossek ML; Culmsee C; Strik H; Koller G; Carl B; Nimsky C
Neuro Oncol; 2015 Nov; 17(11):1474-85. PubMed ID: 25825051
[TBL] [Abstract][Full Text] [Related]
15. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy.
Hoa NT; Ge L; Martini F; Chau V; Ahluwalia A; Kruse CA; Jadus MR
Expert Opin Ther Targets; 2016 Oct; 20(10):1155-67. PubMed ID: 27359377
[TBL] [Abstract][Full Text] [Related]
17. Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide.
Sun S; Lee D; Lee NP; Pu JK; Wong ST; Lui WM; Fung CF; Leung GK
J Neurooncol; 2012 Sep; 109(3):467-75. PubMed ID: 22763762
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Li Q; Chen B; Cai J; Sun Y; Wang G; Li Y; Li R; Feng Y; Han B; Li J; Tian Y; Yi L; Jiang C
PLoS One; 2016; 11(3):e0151815. PubMed ID: 27022952
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
Tian T; Mingyi M; Qiu X; Qiu Y
Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]